• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[骨巨细胞瘤中与生物学行为相关的因素]

[Factors related to biologic behavior in giant cell tumor of bone].

作者信息

Ran Xiang-ying, Huang Jin, Zhang Hui-zhen, Jiang Zhi-ming, Chen Jie

机构信息

Department of Pathology, Shanghai Jiaotong University Affiliated the Sixth People's Hospital, Shanghai 200233, China.

Department of Pathology, Shanghai Jiaotong University Affiliated the Sixth People's Hospital, Shanghai 200233, China. E-mail:

出版信息

Zhonghua Bing Li Xue Za Zhi. 2013 Oct;42(10):669-74.

PMID:24433729
Abstract

OBJECTIVE

To study the histogenesis of giant cell tumor (GCT) and factors related to tumor recurrence, invasiveness and malignant transformation.

METHODS

The clinical features, radiologic classification, surgical approach, pathologic findings, immunophenotypes and follow-up data of 123 cases of GCT were analyzed.

RESULTS

There was a significant correlation between tumor recurrence and radiographic classification (P = 0.032), over-expression of CD147 (P = 0.034) and p53 (P = 0.005), and surgical approach (P = 0.0048) in GCT. The biologic behavior showed no correlation with intramedullary infiltration, cortical bone involvement, parosteal soft tissue extension, tumor thrombi, fusiform changes of mononuclear tumor cells, mitotic count, Ki-67 index, coagulative tumor necrosis, secondary aneurysmal bone cyst formation, and adjoining bony reaction. The positive rate of p63 in stromal cells of GCT (79.7%, 94/118) was significantly higher than that in chondroblastoma (44.7%, 21/47), osteosarcoma (22.2%, 10/45) and other giant cell-rich tumors.

CONCLUSIONS

GCT is a bone tumor of low malignant potential. It is sometimes characterized by locally invasive growth, active proliferation, coagulative necrosis, secondary aneurysmal bone cyst and surrounding bony reaction. It is difficult to predict the biologic behavior of GCT. Over-expression of p53 in the tumor cells and CD147 in all components of GCT correlate with tumor invasiveness, recurrence and malignant transformation. Selection of suitable surgical approach with reference to radiologic classification is considered as an important factor in reducing the recurrence rate.

摘要

目的

研究骨巨细胞瘤(GCT)的组织发生及与肿瘤复发、侵袭和恶变相关的因素。

方法

分析123例GCT的临床特征、放射学分类、手术方式、病理表现、免疫表型及随访资料。

结果

GCT中肿瘤复发与放射学分类(P = 0.032)、CD147过表达(P = 0.034)、p53过表达(P = 0.005)及手术方式(P = 0.0048)之间存在显著相关性。生物学行为与髓内浸润、皮质骨受累、骨膜下软组织延伸、肿瘤血栓、单核肿瘤细胞梭形改变、有丝分裂计数、Ki-67指数、凝固性肿瘤坏死、继发性动脉瘤样骨囊肿形成及相邻骨质反应无关。GCT间质细胞中p63阳性率(79.7%,94/118)显著高于成软骨细胞瘤(44.7%,21/47)、骨肉瘤(22.2%,10/45)及其他富含巨细胞的肿瘤。

结论

GCT是一种低恶性潜能的骨肿瘤。其有时表现为局部侵袭性生长、活跃增殖、凝固性坏死、继发性动脉瘤样骨囊肿及周围骨质反应。难以预测GCT的生物学行为。肿瘤细胞中p53过表达及GCT所有成分中CD147过表达与肿瘤侵袭、复发及恶变相关。参照放射学分类选择合适的手术方式是降低复发率的重要因素。

相似文献

1
[Factors related to biologic behavior in giant cell tumor of bone].[骨巨细胞瘤中与生物学行为相关的因素]
Zhonghua Bing Li Xue Za Zhi. 2013 Oct;42(10):669-74.
2
Denosumab-treated Giant Cell Tumor of Bone Exhibits Morphologic Overlap With Malignant Giant Cell Tumor of Bone.地诺单抗治疗的骨巨细胞瘤与骨恶性巨细胞瘤存在形态学重叠。
Am J Surg Pathol. 2016 Jan;40(1):72-80. doi: 10.1097/PAS.0000000000000506.
3
Factors of local recurrence of giant cell tumor of long bone after treatment: plain radiographs, pathology and surgical procedures.长骨骨巨细胞瘤治疗后局部复发的因素:X线平片、病理学及手术操作
J Med Assoc Thai. 2011 Oct;94(10):1230-7.
4
Expression and localization of extracellular matrix metalloproteinase inducer in giant cell tumor of bone.细胞外基质金属蛋白酶诱导剂在骨巨细胞瘤中的表达及定位
J Cell Biochem. 2003 Aug 15;89(6):1154-63. doi: 10.1002/jcb.10578.
5
P63 expression as a biomarker discriminating giant cell tumor of bone from other giant cell-rich bone lesions.P63表达作为一种区分骨巨细胞瘤与其他富含巨细胞骨病变的生物标志物。
Pathol Res Pract. 2016 Oct;212(10):876-879. doi: 10.1016/j.prp.2016.07.007. Epub 2016 Jul 14.
6
[Giant cell tumor of bone and malignancies in giant cell tumor: a clinicopathologic analysis].[骨巨细胞瘤及骨巨细胞瘤中的恶性肿瘤:临床病理分析]
Zhonghua Bing Li Xue Za Zhi. 2009 May;38(5):312-5.
7
Expression of bone morphogenetic proteins in giant cell tumor of bone.骨形态发生蛋白在骨巨细胞瘤中的表达
Anticancer Res. 2009 Jun;29(6):2219-25.
8
Bisphosphonates reduce local recurrence in extremity giant cell tumor of bone: a case-control study.双膦酸盐可降低肢体骨巨细胞瘤的局部复发率:一项病例对照研究。
Bone. 2008 Jan;42(1):68-73. doi: 10.1016/j.bone.2007.08.038. Epub 2007 Sep 6.
9
[Clinicopathologic differential diagnosis of giant cell-rich osteosarcoma and giant cell tumor of bone].[富含巨细胞的骨肉瘤与骨巨细胞瘤的临床病理鉴别诊断]
Zhonghua Bing Li Xue Za Zhi. 2014 Jun;43(6):379-82.
10
Denosumab-treated giant cell tumor of bone. Its histologic spectrum and potential diagnostic pitfalls.地诺单抗治疗的骨巨细胞瘤。其组织学谱及潜在诊断陷阱。
Hum Pathol. 2017 May;63:89-97. doi: 10.1016/j.humpath.2017.02.008. Epub 2017 Feb 22.

引用本文的文献

1
Rs6757 in microRNA-3976 binding site of CD147 confers risk of hepatocellular carcinoma in South Chinese population.rs6757 位于 CD147 的 microRNA-3976 结合位点,增加华南人群罹患肝细胞癌的风险。
World J Surg Oncol. 2022 Aug 17;20(1):260. doi: 10.1186/s12957-022-02724-w.
2
The biological function and clinical utilization of CD147 in human diseases: a review of the current scientific literature.CD147在人类疾病中的生物学功能及临床应用:当前科学文献综述
Int J Mol Sci. 2014 Sep 29;15(10):17411-41. doi: 10.3390/ijms151017411.